At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
01066 WEIGAO GROUP
Closed Easter Monday 04-02 16:08:21
3.730
-0.110
-2.86%
High3.910Low3.650Vol69.09M
Open3.840D1 Closing3.840Amplitude6.77%
Mkt Cap16.86BTradable Cap16.68BTotal Shares4.52B
T/O256.68MT/O Rate1.54%Tradable Shares4.47B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Lilly's Oral GLP-1 Weight Loss Drug Receives FDA Approval, Offering Daily Pill Alternative to Injections
Deep News  ·  04-03
Lilly's Oral GLP-1 Weight Loss Drug Receives FDA Approval, Offering Daily Pill Alternative to Injections
WEIGAO GROUP Completes CSRC Registration for Conversion of 48.3 Million Non-Tradable Shares to H Shares
Stock News  ·  04-01
WEIGAO GROUP Completes CSRC Registration for Conversion of 48.3 Million Non-Tradable Shares to H Shares
Weigao Medical Polymer wins CSRC filing for 48.3 million unlisted-to-H share conversion
Reuters  ·  04-01
Weigao Medical Polymer wins CSRC filing for 48.3 million unlisted-to-H share conversion
WEIGAO GROUP repurchases 0.50 million H-shares for HK$1.90 million; treasury stock rises to 48.44 million
Bulletin Express  ·  04-01
WEIGAO GROUP repurchases 0.50 million H-shares for HK$1.90 million; treasury stock rises to 48.44 million
WEIGAO GROUP Spends HK$1.902 Million to Buy Back 500,000 Shares on April 1
Stock News  ·  04-01
WEIGAO GROUP Spends HK$1.902 Million to Buy Back 500,000 Shares on April 1
Shandong Weigao Group Medical Polymer Company Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Simply Wall St.  ·  04-01
Shandong Weigao Group Medical Polymer Company Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Weigao Group buys back 1.67 million H-shares, treasury stock rises to 47.94 million
Bulletin Express  ·  03-31
Weigao Group buys back 1.67 million H-shares, treasury stock rises to 47.94 million
TCL Electronics Rises, Weigao and Meitu Slump as Hong Kong Earnings Wrap Up
MT Newswires Live  ·  03-30
TCL Electronics Rises, Weigao and Meitu Slump as Hong Kong Earnings Wrap Up
WEIGAO GROUP repurchases 4.69 million H-shares, treasury stock rises to 46.27 million
Bulletin Express  ·  03-30
WEIGAO GROUP repurchases 4.69 million H-shares, treasury stock rises to 46.27 million
WEIGAO GROUP Spends HK$17.94 Million on Share Buyback
Stock News  ·  03-30
WEIGAO GROUP Spends HK$17.94 Million on Share Buyback
Stock Track | WEIGAO GROUP Plummets 17.03% Intraday on Disappointing H2 Results and VBP Margin Pressure
Stock Track  ·  03-30
Stock Track | WEIGAO GROUP Plummets 17.03% Intraday on Disappointing H2 Results and VBP Margin Pressure
Goldman Sachs Trims WEIGAO GROUP Target Price to HK$6, Keeps "Buy" Rating
Stock News  ·  03-30
Goldman Sachs Trims WEIGAO GROUP Target Price to HK$6, Keeps "Buy" Rating
Weigao Group Releases Overseas Regulatory Announcement on Subsidiary’s SSE Disclosure
Bulletin Express  ·  03-27
Weigao Group Releases Overseas Regulatory Announcement on Subsidiary’s SSE Disclosure
Weigao Group releases overseas regulatory update on subsidiary Weigao Orthopaedic’s disclosure to Shanghai Stock Exchange
Bulletin Express  ·  03-27
Weigao Group releases overseas regulatory update on subsidiary Weigao Orthopaedic’s disclosure to Shanghai Stock Exchange
WEIGAO GROUP to Acquire Land in Weihai for 39.71 Million Yuan
Stock News  ·  03-27
WEIGAO GROUP to Acquire Land in Weihai for 39.71 Million Yuan
Shandong Weigao Group Medical Polymer revises and adopts board diversity policy; adoption date set for March 27, 2026
Reuters  ·  03-27
Shandong Weigao Group Medical Polymer revises and adopts board diversity policy; adoption date set for March 27, 2026
Shandong Weigao Group Medical Polymer agrees to buy industrial land use right for RMB 40 million; payment settles in cash
Reuters  ·  03-27
Shandong Weigao Group Medical Polymer agrees to buy industrial land use right for RMB 40 million; payment settles in cash
Weigao Group acquires 76,342 sq.m. industrial land use right for RMB39.71 million from connected party
Bulletin Express  ·  03-27
Weigao Group acquires 76,342 sq.m. industrial land use right for RMB39.71 million from connected party
Shandong Weigao Group Medical Polymer - Deal for RMB39.7 Mln
THOMSON REUTERS  ·  03-27
Shandong Weigao Group Medical Polymer - Deal for RMB39.7 Mln
Weigao Group Medical Polymer Declares FY2025 Final Dividend of RMB0.06 per Share
Bulletin Express  ·  03-27
Weigao Group Medical Polymer Declares FY2025 Final Dividend of RMB0.06 per Share

Introduction

Company Name.
WEIGAO GROUP
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Shandong Weigao Group Medical Polymer Co Ltd is a China-based company principally engaged in the research and development, production and sale of medical device products. The Company operates its businesses through six segments. The Medical Device Products segment produces and sells clinical care, medical testing, anesthesia and surgical related products and other consumables. The Orthopaedic Products segment produces and sells orthopaedic products, including tissue repair product line. The Interventional Products segment produces and sells tumour and blood vessel interventional instruments. The Pharma Packaging Products segment produces and sells pre-filled syringes and flushing syringes. The Blood Management Products segment produces and sells blood collection, irradiation, storage, separation and sterilization products. The Others segment engages in finance lease and factoring business. The Company mainly operates its businesses in the domestic and overseas markets.
Issue price:
--